One year after first case of COVID-19 in Ghana: epidemiology, challenges and accomplishments

Amponsah, Seth Kwabena; Tagoe, Benjamin; Afriyie, Daniel Kwame

doi:10.11604/pamj.2021.39.226.29069

Cited by 8 publications

(7 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…No information on the vaccination status of the study participants was collected at the time of recruitment as the roll out of the vaccination campaigns only began after completion of recruitment and sample collection. The mass vaccination of the population in Ghana started in May 2021 [ 9 ], in July 2021 in Madagascar [ 10 ], and Burkina Faso only received vaccine doses in November 2021 [ 11 ].…”

Section: Methodsmentioning

confidence: 99%

High seroprevalence of SARS-CoV-2 in Burkina-Faso, Ghana and Madagascar in 2021: a population-based study

et al. 2022

View full text Add to dashboard Cite

Background The current COVID-19 pandemic affects the entire world population and has serious health, economic and social consequences. Assessing the prevalence of COVID-19 through population-based serological surveys is essential to monitor the progression of the epidemic, especially in African countries where the extent of SARS-CoV-2 spread remains unclear. Methods A two-stage cluster population-based SARS-CoV-2 seroprevalence survey was conducted in Bobo-Dioulasso and in Ouagadougou, Burkina Faso, Fianarantsoa, Madagascar and Kumasi, Ghana between February and June 2021. IgG seropositivity was determined in 2,163 households with a specificity improved SARS-CoV-2 Enzyme-linked Immunosorbent Assay. Population seroprevalence was evaluated using a Bayesian logistic regression model that accounted for test performance and age, sex and neighbourhood of the participants. Results Seroprevalence adjusted for test performance and population characteristics were 55.7% [95% Credible Interval (CrI) 49·0; 62·8] in Bobo-Dioulasso, 37·4% [95% CrI 31·3; 43·5] in Ouagadougou, 41·5% [95% CrI 36·5; 47·2] in Fianarantsoa, and 41·2% [95% CrI 34·5; 49·0] in Kumasi. Within the study population, less than 6% of participants performed a test for acute SARS-CoV-2 infection since the onset of the pandemic. Conclusions High exposure to SARS-CoV-2 was found in the surveyed regions albeit below the herd immunity threshold and with a low rate of previous testing for acute infections. Despite the high seroprevalence in our study population, the duration of protection from naturally acquired immunity remains unclear and new virus variants continue to emerge. This highlights the importance of vaccine deployment and continued preventive measures to protect the population at risk.

show abstract

Section: Methodsmentioning

confidence: 99%

High seroprevalence of SARS-CoV-2 in Burkina-Faso, Ghana and Madagascar in 2021: a population-based study

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Ideally, knowledge of the pandemic should increase with the passage of time [ 36 ]. Reasons for this comparatively lower knowledge of nurses in Ghana may be due to the less severe nature of the pandemic in the country [ 37 ]. Typically, health workers would usually make efforts to learn about any emerging disease.…”

Section: Discussionmentioning

confidence: 99%

Predictors of knowledge and adherence to COVID-19 safety protocols among nurses at health facilities in Tamale Metropolis of Northern Ghana

2022

View full text Add to dashboard Cite

Background Corona Virus Disease of 2019 (COVID-19) emerged in 2019 and caused widespread disruption to many facets of life, including healthcare. Healthcare workers, particularly nurses, became the front-line fighters against the pandemic, making it imperative to comply with recommended safety protocols. However, many nurses were infected by the virus in the Tamale Metropolis, raising concerns regarding their level of adherence to the safety protocols. This study assessed the predictors of knowledge and adherence to COVID-19 safety protocols among nurses at selected health facilities in the Tamale Metropolis of northern Ghana. Methods A facility based cross-sectional study design was adopted and 339 nurses from six (6) public health facilities in the Tamale Metropolis were recruited for the study using questionnaires. The questionnaires were transformed into Google Forms for respondents to answer online via WhatsApp or email. The data were exported from the Google spreadsheet into SPSS and analyzed using descriptive and inferential statistics. Results Of the 339 participants, 60.2% were classified as having adequate knowledge while only 9.1% demonstrated high adherence to COVID-19 safety protocols. Knowledge of COVID-19 was predicted by source of information, and marital status, whereas health facility types predicted level of adherence. The odds of having adequate knowledge were higher among unmarried nurses (AOR = 1.94; 95% CI: 1.16–3.25; p = 0.012) and nurses using social media (AOR = 1.80; 95%CI 1.02–3.18; p = 0.042) compared to their counterparts. Meanwhile, primary health care nurses (AOR = 0.24; 95% CI = 0.12–0.50; p<0.001) and secondary health care nurses (AOR = 0.52; 95% CI = 0.31–0.88; P = 0.016) had reduced odds of exhibiting higher adherence compared to nurses from tertiary-level facility. Conclusion In this study, we found that knowledge was high but adherence to COVID-19 safety protocols was low. We suggest that facility managers should enforce compliance of their staff to the safety protocols to prevent spread of the virus within healthcare settings.

show abstract

“…In Ghana, the government committed to acquiring COVID-19 vaccines on December 20, 2020 [25]. Ghana was the first country to receive COVID-19 vaccines from the COVAX initiative and began its first vaccine roll out on March 1, 2021 [26,27,28] with the AstraZeneca vaccine. Johnson & Johnson (J&J), Moderna, Pfizer, and Sputnik V were the COVID-19 vaccines also approved and administered in Ghana.…”

Section: Covid-19 Vaccination Analysis For Ghanamentioning

confidence: 99%

Modelling the impact of vaccination on the COVID-19 pandemic in African countries

Mathebula¹,

Amankwah²,

Amouzouvi³

et al. 2022

Preprint

View full text Add to dashboard Cite

The rapid development of vaccines to combat COVID-19 is a great scientific achievement. In addition to non-pharmaceutical measures put in place to contain of the pandemic, pharmacological measures have been incorporated in the battle against the SARS-CoV-2, especially with the commencement of vaccination in early December 2020. This study used the SIDARTHE-V model, i.e.an extension of the SIDARTHE model with the impact of vaccination roll outs.We assessed the potential impact of vaccination in reducing the severity (deadly nature) of the virus in African countries. Model parameters were extracted by fitting simultaneously the COVID-19 cumulative data of active cases, recoveries, deaths and full vaccinations reported by the governments of Ghana, Kenya,

show abstract

One year after first case of COVID-19 in Ghana: epidemiology, challenges and accomplishments

Cited by 8 publications

References 7 publications

High seroprevalence of SARS-CoV-2 in Burkina-Faso, Ghana and Madagascar in 2021: a population-based study

High seroprevalence of SARS-CoV-2 in Burkina-Faso, Ghana and Madagascar in 2021: a population-based study

Predictors of knowledge and adherence to COVID-19 safety protocols among nurses at health facilities in Tamale Metropolis of Northern Ghana

Modelling the impact of vaccination on the COVID-19 pandemic in African countries

Contact Info

Product

Resources

About